1. P01.15 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in macroscopic stage III melanoma patients stratified according to interferon-gamma (IFN-gamma) signature – the DONIMI study. (1st October 2020) Authors: Reijers, ILM; Rozeman, EA; Dimitriadis, P; Krijgsman, O; Bosch, LJW; Cornelissen, S; Bouwman, J; Versluis, JM; Rao, D; van de Wiel, B; Spillane, AJ; Scolyer, RA; Menzies, AM; van Akkooi, ACJ; Long, GV; Blank, CU Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗